...
首页> 外文期刊>Reumatologia >Cardiovascular system involvement in systemic lupus erythematosus – review and own observations. Serological risk factor of cardiological complications
【24h】

Cardiovascular system involvement in systemic lupus erythematosus – review and own observations. Serological risk factor of cardiological complications

机译:心血管系统参与系统性红斑狼疮–复习并自己观察。心脏病并发症的血清学危险因素

获取原文
           

摘要

Systemic lupus erythematosus is an autoimmune disease, in the course of which involvement of the circulatory system is one of the common systemic manifestations, very important from the prognostic point of view. Involvement the heart affects most commonly pericardium and valvular system; myocardium is affected rarely. Patients with SLE have a high risk of early atherosclerosis in the form of coronary disease and myocardial infarct. Unlike in the general population, risk factors of cardiovascular complications in the SLE patients are mainly antiphospholipid antibodies, duration of the disease, duration of glucocorticoid therapy, as well as lipid disorders, anti-oxLDL antibodies, and high levels of CRP, a1-antitripsin and homocystein. Own observations on cardiac manifestation in the SLE patients and serological risk factors related to cardiac involvement are discussed in the paper.
机译:系统性红斑狼疮是一种自身免疫性疾病,在此过程中,循环系统受累是常见的系统性表现之一,从预后的角度来看非常重要。心脏受累最常影响心包和瓣膜系统;心肌很少受到影响。 SLE患者以冠心病和心肌梗塞的形式出现早期动脉粥样硬化的高风险。与普通人群不同,SLE患者发生心血管并发症的危险因素主要是抗磷脂抗体,疾病持续时间,糖皮质激素治疗的持续时间以及脂质异常,抗oxLDL抗体和高水平的CRP,a1-antitripsin和半胱氨酸。本文讨论了SLE患者心脏表现的自身观察以及与心脏受累相关的血清学危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号